HRS4R
Vull donar
Firma
RAFEL MARCOS-GRAGERA
Posició
Cap de Grup - R4
Caps de Grup - R4

Projectes

Codi oficial: Projecte IJC - Dr. Rafael Marcos-Gragera Data inici: 01/01/2021 Data fi: 31/12/2024 Investigador/a principal: RAFEL MARCOS GRAGERA Organisme finançador: FUNDACIÓ INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS Ajuda: 12,500 €

Publicacions

0

Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3)

Neuro-Oncology, 2023, 25, 580-592 dx.doi.org/10.1093/neuonc/noac217

Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Font R, Marcos-Gragera R, Puigdemont M, Viñas G, Carulla M, Espinàs JA, Galceran J, Izquierdo Á, Borràs JM

Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 dx.doi.org/10.3390/ijerph20010405

Posso M, Alcántara R, Vázquez I, Comerma L, Baré M, Louro J, Quintana MJ, Román M, Marcos-Gragera R, Vernet-Tomas M, Saladie F, Vidal C, Bargalló X, Peñalva L, Sala M, Castells X

Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening

EUROPEAN RADIOLOGY, 2022, 32, 621-629 dx.doi.org/10.1007/s00330-021-08118-y

Sanvisens A, Ameijide A, Carulla M, Marcos-Gragera R

Estimates of the incidence of hematological neoplasms in Spain, 2021: Study of the Spanish Network of Cancer Registries (REDECAN)

MEDICINA CLINICA, 2022, 158, 284-290 dx.doi.org/10.1016/j.medcli.2021.09.035

Solans M, Sanvisens A, Ameijide A, Merino S, Rojas D, Alemán A, Banqueri E, Chico M, Marcos AI, de Castro V, Gil L, de Munain AL, Puigdemont M, Sánchez MJ, Perucha J, Ruiz-Armengol P, Chirlaque MD, Guevara M, Carulla M, Marcos-Gragera R

Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries

SCIENTIFIC REPORTS, 2022, 12, 323-323 dx.doi.org/10.1038/s41598-021-03734-6

Carbó-Bagué A, Rubió-Casadevall J, Puigdemont M, Sanvisens A, Oliveras G, Coll M, Del Olmo B, Perez-Bueno F, Marcos-Gragera R

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14030780

Hernández-García M, Molina-Barceló A, Vanaclocha-Espi M, Zurriaga Ó, Pérez-Gómez B, Aragonés N, Amiano P, Altzibar JM, Castaño-Vinyals G, Sala M, Ederra M, Martín V, Gómez-Acebo I, Vidal C, Tardón A, Marcos-Gragera R, Pollán M, Kogevinas M, Salas D

Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study)

CANCER CAUSES & CONTROL, 2022, 33, 125-136 dx.doi.org/10.1007/s10552-021-01511-4
0

No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph19063605
0

Bayesian variable selection and survival modeling: assessing the Most important comorbidities that impact lung and colorectal cancer survival in Spain

BMC MEDICAL RESEARCH METHODOLOGY, 2022, 22, 95-95 dx.doi.org/10.1186/s12874-022-01582-0

Formulari de contacte

Coneix l’IDIBGI!

menu